Global Postoperative Nausea and Vomiting (PONV) Market Research Report 2022

Market Analysis and Insights: Global Postoperative Nausea and Vomiting (PONV) Market
The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.
The global Postoperative Nausea and Vomiting (PONV) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Postoperative Nausea and Vomiting (PONV) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Postoperative Nausea and Vomiting (PONV) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Postoperative Nausea and Vomiting (PONV) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Postoperative Nausea and Vomiting (PONV) market.
Global Postoperative Nausea and Vomiting (PONV) Scope and Market Size
Postoperative Nausea and Vomiting (PONV) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Non-pharmacologic Treatment
Others
Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline